Various therapies such as radiation therapy, intra-arterial chemotherapy, concurrent chemoradiotherapy, and surgery have been used to treat oropharyngeal cancers. Here, we report the good outcome achieved using S-1 and nedaplatin with concurrent radiotherapy (SN therapy) to treat a patient with oropharyngeal cancer (T4aN3M0).
A 67-year-old man was referred to our hospital for evaluation because of discomfort in the pharyngeal region and a cervical mass. Clinical and cytologic examinations revealed a large squamous cell carcinoma in the left peritonsillar area, which was occupying the oropharyngeal lumen. Computed tomography revealed oropharyngeal cancer (T4aN3M0), and the patient was treated with SN therapy.
Although the primary tumor had disappeared on contrast-enhanced computed tomography after the first-line treatment, left cervical lymphadenopathy remained and was classified as level V by ultrasound-guided fine-needle aspiration cytology. However, no viable cancer cells were observed in the lymph nodes excised during left neck dissection, indicating that a complete response had been achieved with the first-line treatment.
No recurrence or metastasis has been observed at follow-up, although this is a relatively short follow-up period of only 8 months to date. This case suggests that SN therapy can be effective for the treatment of advanced oropharyngeal cancer from the viewpoints of radical treatment and preservation of organ function.
View full abstract